Literature DB >> 10475534

Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS).

A C Moorman1, S D Holmberg, S I Marlowe, J C Von Bargen, B G Yangco, F J Palella, D J Ward, M O Loveless, J Fuhrer, P Joseph, W A Alexander, D J Aschman.   

Abstract

PURPOSE: Most HIV-infected persons are now treated as ambulatory patients. Obtaining continually updated data about these patients' changing conditions, therapies, and reimbursement is essential to health care provision and planning. The systematic tracking of patient medical and laboratory information in an ongoing commercial data collection program (The Health Research Network) allows clinicians to better understand health outcomes, practice patterns, and epidemiologic trends for their patients.
METHODS: To evaluate trends in conditions and therapies of ambulatory HIV-infected patients, we analyzed such data electronically and prospectively collected in the HIV Outpatient Study (HOPS) from 1992 through 1996 from 1876 patients seen in 11,755 clinic visits to ten HIV clinical practices.
RESULTS: Patients were as likely to be diagnosed with Mycobacterium avium complex ([MAC] 5.4 cases per 100 person-years) or wasting syndrome (7.8 cases per 100 person-years), as Pneumocystis carinii pneumonia ([PCP]; 7.6 cases per 100 person-years) or Kaposi sarcoma ([KS]; 6.9 cases per 100 person-years). A nested analysis showed that HIV-infected cigarette smokers were at substantially greater risk of pneumonia (relative hazard [RH] = 2.3), bronchitis (RH = 1.7) and hairy leukoplakia (RH = 1.9) than nonsmokers. By 1996, 35 (56%) of 62 patients with PCP, 9 (30%) of 30 patients with other pneumonias, 28 (90%) of 31 patients with KS, 35 (73%) of 48 patients with MAC, and 24 (63%) of 38 patients with cytomegalovirus retinitis were treated without hospitalization.
CONCLUSIONS: The HOPS provides continually updated information on the changing characteristics, conditions, and therapy of ambulatory HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475534     DOI: 10.1016/s1047-2797(99)00005-8

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  14 in total

1.  Risk factors for hepatitis C infection among Vietnam era veterans versus nonveterans: results from the Chronic Hepatitis Cohort Study (CHeCS).

Authors:  Joseph A Boscarino; Alexandra Sitarik; Stuart C Gordon; Loralee B Rupp; David R Nerenz; Vinutha Vijayadeva; Mark A Schmidt; Emily Henkle; Mei Lu
Journal:  J Community Health       Date:  2014-10

2.  Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions.

Authors:  Alan E Greenberg; Harlen Hays; Amanda D Castel; Thilakavathy Subramanian; Lindsey Powers Happ; Maria Jaurretche; Jeff Binkley; Mariah M Kalmin; Kathy Wood; Rachel Hart
Journal:  J Am Med Inform Assoc       Date:  2015-12-31       Impact factor: 4.497

3.  An epidemic in evolution: the need for new models of HIV care in the chronic disease era.

Authors:  Carolyn Chu; Peter A Selwyn
Journal:  J Urban Health       Date:  2011-06       Impact factor: 3.671

4.  Long-term immunologic and virologic responses on raltegravir-containing regimens among ART-experienced participants in the HIV Outpatient Study.

Authors:  Kate Buchacz; Ryan Wiegand; Carl Armon; Joan S Chmiel; Kathleen Wood; John T Brooks; Frank J Palella
Journal:  HIV Clin Trials       Date:  2015-07-01

5.  Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS.

Authors:  Jonathan Shuter; Steven L Bernstein; Alyson B Moadel
Journal:  Am J Health Behav       Date:  2012-01

6.  Neutropenia in HIV-Infected Kenyan Women Receiving Triple Antiretroviral Prophylaxis to Prevent Mother-to-Child HIV Transmission Is Not Associated with Serious Clinical Sequelae.

Authors:  A Danielle Iuliano; Paul J Weidle; John T Brooks; Rose Masaba; Sonali Girde; Richard Ndivo; Paul Ogindo; Paul Omolo; Clement Zeh; Timothy K Thomas
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-09-30

7.  Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?

Authors:  Bienvenido G Yangco; Kate Buchacz; Rose Baker; Frank J Palella; Carl Armon; John T Brooks
Journal:  AIDS Patient Care STDS       Date:  2014-05-15       Impact factor: 5.078

Review 8.  The HIV Outpatient Study-25 Years of HIV Patient Care and Epidemiologic Research.

Authors:  Kate Buchacz; Carl Armon; Frank J Palella; Richard M Novak; Jack Fuhrer; Ellen Tedaldi; Douglas Ward; Cynthia Mayer; Linda Battalora; Kimberly Carlson; Stacey Purinton; Marcus Durham; Jun Li
Journal:  Open Forum Infect Dis       Date:  2020-04-11       Impact factor: 3.835

9.  Yeast two hybrid analyses reveal novel binary interactions between human cytomegalovirus-encoded virion proteins.

Authors:  Aaron To; Yong Bai; Ao Shen; Hao Gong; Sean Umamoto; Sangwei Lu; Fenyong Liu
Journal:  PLoS One       Date:  2011-04-01       Impact factor: 3.240

10.  Trends in the Treatment of Anemia Using Recombinant Human Erythropoietin in Patients with HIV Infection.

Authors:  Patrick S Sullivan; Debra L Hanson; James T Richardson; John T Brooks
Journal:  Open AIDS J       Date:  2011-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.